Nutrineal Peritoneal Dialysis 4 (Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin)

The formulation delivers a balanced profile of essential and non‑essential amino acids directly into the peritoneal cavity. These amino acids are absorbed across the peritoneal membrane into the bloodstream, supplying substrates for protein synthesis and maintaining nitrogen balance in the patient.

The prescribed dose is determined by the treating physician based on the patient’s nutritional status, dialysis prescription, and laboratory parameters. Dosing is individualized and administered via the peritoneal dialysis exchange as directed by the clinician.

Safety in pregnancy and lactation has not been established. The product should be used only if the potential benefit justifies the potential risk to the mother and fetus, and it must be under close medical supervision.

Submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Nutrineal provides a comprehensive blend of ten amino acids in concentrations optimized for intraperitoneal use, matching or exceeding the amino acid profile of many competing formulations. Choice often depends on regional availability, cost, and specific patient tolerance.

Store at ambient temperature, below 25 °C, in the original sealed container. Protect from direct sunlight, moisture and extreme temperature fluctuations. Do not freeze the solution; keep it out of reach of children.

The solution is added to the peritoneal dialysis exchange bag and introduced into the peritoneal cavity during a standard dialysis dwell. Administration follows the prescribed exchange volume and dwell time set by the healthcare provider.

Serious adverse events include allergic reactions such as anaphylaxis, peritonitis, and significant electrolyte disturbances. Patients should be monitored for signs of hypersensitivity, abdominal pain, fever, or abnormal laboratory values, and medical attention should be sought promptly if they occur.

Patients with known hypersensitivity to any of the amino acids in the formulation, those with severe hepatic impairment, or individuals with uncontrolled electrolyte imbalances should not receive the product unless a physician determines that the benefits outweigh the risks.